Apimeds Pharmaceuticals US (APUS) Assets (2023 - 2025)
Apimeds Pharmaceuticals US's (APUS) quarterly Assets came in at $164.2 million in Q4 2025, up 1257338.43% YoY from N/an in Q4 2024, and up 1674.95% on a QoQ basis from $9.3 million in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Assets (2023 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US (APUS) has 3 years of Assets data on file, last reported at $164.2 million in Q4 2025.
- Quarterly Assets rose 1257338.43% year-over-year to $164.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $164.2 million (up 1257338.43% YoY) and the FY2025 annual result came in at $164.2 million, up 1257338.43% from the prior year.
- Assets climbed to $164.2 million in Q4 2025, from $9.3 million in the prior quarter.
- In the past five years, Assets ranged from a high of $164.2 million in Q4 2025 to a low of $13057.0 in Q4 2024.
- A 3-year average of $30.8 million and a median of $4.8 million in 2023 frame the typical range for Assets.
- Annual changes were most pronounced in 2024 — Assets sank 96.91% — and 2025, when it surged 1257338.43%.
- Tracing APUS's Assets over 3 years: stood at $422076.0 in 2023, then slumped by 96.91% to $13057.0 in 2024, then surged by 1257338.43% to $164.2 million in 2025.
- The last three Assets figures came in at $164.2 million (Q4 2025), $9.3 million (Q3 2025), and $10.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 6.18 Bn |
| 10 | Apimeds Pharmaceuticals US | 7.12 Mn | 7.12 Mn | - | 127.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 164.18 Mn |
| Sep 30, 2025 | 9.25 Mn |
| Jun 30, 2025 | 10.55 Mn |
| Mar 31, 2025 | 259,904.00 |
| Dec 31, 2024 | 13,057.00 |
| Dec 31, 2023 | 422,076.00 |